Recently, Amy Seybert, Sandra Kane-Gill, and Lawrence Kobulinsky presented "Introducing Human Patient Simulation to Pharmacy" at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Orlando, Florida. ASHP is a 35,000-member professional association that is comprised of pharmacy professionals who practice in hospitals, health maintenance organizations, and other components of health care systems. ASHP is the only national organization of hospital and health-system pharmacists and has a long history of improving medication use and enhancing patient safety. The ASHP meeting is the largest gathering of pharmacists in the world. With its focus on improving patient care, the Midyear meeting is routinely attended by more than 20,000 pharmacy professionals from over 80 countries.
This was the first simulation program offered at ASHP and represented cutting edge continuing education for pharmacists. The new Accreditation Council for Pharmacy Education (ACPE) guidelines require an active learning component to each continuing education session and human patient simulation with high-fidelity SimMan offered an excellent opportunity for pharmacists to receive hands-on training.
Dr. Seybert, Associate Director, Pharmacy Programs at WISER, introduced human patient simulation and the history of use within other disciplines. Additionally, Dr. Kane-Gill overviewed the benefits of simulation training for the enhancement of patient and medication safety. During the presentation, Dr. Seybert overviewed all of the uses of simulation within the University of Pittsburgh School of Pharmacy curriculum. In collaboration with WISER, simulation has been used in the following areas of pharmacy education:
The final component to the ASHP program was "hands-on" application of simulation technology. Dr. Seybert and Mr. Kobulinsky presented patient case scenarios for the audience to participate in caring for the patient. The pharmacy audience was able to administer medications to each "patient" and see the realistic clinical effect of the therapies. While debriefing each scenario, Dr. Seybert and Mr. Kobulinsky were able to display the necessary programming of the SimMan software and many audience members focused on this application since they have collaborative efforts ongoing with other simulation centers in the country and across the world.